GSK (GSK) stock
GSK technical analysis
Oscillators
Summary
Moving averages
| Oscillators | Value | Signal |
|---|---|---|
| RSI (14) | 45.89 | Neutral |
| Stochastic %K (14, 3, 3) | 27.36 | Neutral |
| CCI (20) | -64.49 | Neutral |
| ADX (14) | 23.15 | Neutral |
| Awesome Oscillator | 0.199 | Neutral |
| Momentum (10) | -0.475 | Buy |
| MACD (12, 26) | 0.031 | Sell |
| Stoch RSI (3, 3, 14, 14) | 7.297 | Neutral |
| Williams %R (14) | -72.64 | Neutral |
| Bull Bear Power | -0.489 | Neutral |
| Ultimate Oscillator (7, 14, 28) | 37.48 | Neutral |
| Moving averages | Value | Signal |
|---|---|---|
| EMA (10) | £18.69 | Sell |
| SMA (10) | £18.85 | Sell |
| EMA (20) | £18.70 | Sell |
| SMA (20) | £18.75 | Sell |
| EMA (30) | £18.66 | Sell |
| SMA (30) | £18.66 | Sell |
| EMA (50) | £18.65 | Sell |
| SMA (50) | £18.54 | Sell |
| EMA (100) | £18.78 | Sell |
| SMA (100) | £18.80 | Sell |
| EMA (200) | £18.73 | Sell |
| SMA (200) | £19.50 | Sell |
| Ichimoku Base Line (9, 26, 52, 26) | £18.67 | Sell |
| VWMA (20) | £18.66 | Sell |
| Hull MA (9) | £18.31 | Buy |
Support & resistance levels
Resistance
- R5£22.03+19.58%Moderate
- R4£21.58+17.12%Weak
- R3£20.96+13.76%Weak
- R2£20.53+11.41%Moderate
- R1£19.35+5.05%Strong
Support
- S1£17.95-2.59%Strong
- S2£16.88-8.40%Moderate
- S3£15.92-13.60%Weak
- S4£14.55-21.03%Weak
Levels are detected automatically from swing highs and lows on the daily chart and clustered by volatility (ATR). Strength reflects the number of times price reacted at each level.
| Pivot points (daily) | S3 | S2 | S1 | P | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | £17.71 | £17.96 | £18.12 | £18.36 | £18.52 | £18.76 | £18.92 |
| Fibonacci | £17.96 | £18.11 | £18.21 | £18.36 | £18.51 | £18.61 | £18.76 |
| Camarilla | £18.16 | £18.20 | £18.23 | £18.36 | £18.31 | £18.34 | £18.38 |
| Woodie | £17.67 | £17.94 | £18.07 | £18.34 | £18.47 | £18.74 | £18.87 |
| DeMark | — | — | £18.04 | £18.32 | £18.44 | — | — |
GSK price forecast
| Horizon | Bear case (95%) | Low (68%) | Trend target | High (68%) | Bull case (95%) |
|---|---|---|---|---|---|
| 5 trading days | £17.16 | £17.79 | £18.44 +0.1% | £19.12 | £19.83 |
| 21 trading days | £15.95 | £17.18 | £18.50 +0.4% | £19.93 | £21.46 |
| 63 trading days | £14.43 | £16.41 | £18.66 +1.3% | £21.22 | £24.13 |
The technical bias for GSK is bearish (overall rating: Sell).
Bullish scenario: a sustained break above £19.35 would open the way toward £20.53.
Bearish scenario: a daily close below £17.95 could extend the decline toward £16.88.
Statistical ranges are based on historical volatility and trend, not a guarantee of future prices. Not financial advice.
About GSK
GSK (GSK) shares are trading at £18.43, up +0.85% today. The company belongs to the Health Care sector and has a market capitalization of £73.86B.
The stock’s 52-week range is £16.90 – £22.82, with a price-to-earnings ratio of 17.1. It has moved -2.36% over the past week and +5.29% over the past month.
On the daily chart the overall technical rating for GSK is Sell, with the 14-day RSI at 45.9. The nearest support is at £17.95 and the nearest resistance at £19.35.
Related markets
AllStock market news
-
Bitcoin Bounces Off Two-Year Lows. Could Crypto Rescue Stocks on Monday?Barron's1 hr. ago
-
The S&P 500 Is Now Below Every Wall Street Year-End Target for 2026Yahoo Finance1 hr. ago
-
2 Financial Stocks to Buy Near Their 52-Week LowsThe Motley Fool2 hr. ago
-
The sudden reversal in the stock market, and what comes nextThe Washington Post2 hr. ago
-
Nasdaq Starts Charging for Financial Crime AI Agents as 850 Customers Sign OnYahoo Finance2 hr. ago